More potent DAPT strategies and oral anticoagulation were tied to worse outcomes and should be avoided, researchers say.
Background: Prasugrel is a novel third-generation thienopyridine P2Y12 receptor antagonist with more rapid, potent, and consistent platelet inhibition than clopidogrel. [23] Aim: Compare the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback